{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T20:08:24Z","timestamp":1794686904997,"version":"4.9.1"},"reference-count":54,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Meath Foundation Ireland","award":["Research Award 2019"],"award-info":[{"award-number":["Research Award 2019"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Rett Syndrome (RTT) is a neurodevelopmental disorder associated with mutations in the gene MeCP2, which is involved in the development and function of cortical networks. The clinical presentation of RTT is generally severe and includes developmental regression and marked neurologic impairment. Insulin-Like growth factor 1 (IGF1) ameliorates RTT-relevant phenotypes in animal models and improves some clinical manifestations in early human trials. However, it remains unclear whether IGF1 treatment has an impact on cortical electrophysiology in line with MeCP2\u2019s role in network formation, and whether these electrophysiological changes are related to clinical response. We performed clinical assessments and resting-state electroencephalogram (EEG) recordings in eighteen patients with classic RTT, nine of whom were treated with IGF1. Among the treated patients, we distinguished those who showed improvements after treatment (responders) from those who did not show any changes (nonresponders). Clinical assessments were carried out for all individuals with RTT at baseline and 12 months after treatment. Network measures were derived using statistical modelling techniques based on interelectrode coherence measures. We found significant interaction between treatment groups and timepoints, indicating an effect of IGF1 on network measures. We also found a significant effect of responder status and timepoint, indicating that these changes in network measures are associated with clinical response to treatment. Further, we found baseline variability in network characteristics, and a machine learning model using these measures applied to pretreatment data predicted treatment response with 100% accuracy (100% sensitivity and 100% specificity) in this small patient group. These results highlight the importance of network pathology in RTT, as well as providing preliminary evidence for the potential of network measures as tools for the characterisation of disease subtypes and as biomarkers for clinical trials.<\/jats:p>","DOI":"10.3390\/brainsci10080515","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T07:45:57Z","timestamp":1596440757000},"page":"515","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Functional Network Mapping Reveals State-Dependent Response to IGF1 Treatment in Rett Syndrome"],"prefix":"10.3390","volume":"10","author":[{"given":"Conor","family":"Keogh","sequence":"first","affiliation":[{"name":"Department of Surgery, University Hospital Limerick, V94 F858 Limerick, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6949-2822","authenticated-orcid":false,"given":"Giorgio","family":"Pini","sequence":"additional","affiliation":[{"name":"Tuscany Rett Center, Ospedale Versilia, SS 1 Via Aurelia, 335, 55041 Camaiore LU, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Gemo","sequence":"additional","affiliation":[{"name":"Tuscany Rett Center, Ospedale Versilia, SS 1 Via Aurelia, 335, 55041 Camaiore LU, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Emory University School of Medicine; Whitehead Biomedical Research Building, 615 Michael Street, Suite 301, Atlanta, GA 30322, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Tropea","sequence":"additional","affiliation":[{"name":"Neuropsychiatric Genetics, Trinity Centre for Health Sciences, St. James Hospital, D08 NHY1 Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: From clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"ref_2","first-page":"118","article-title":"Rett syndrome: A prototypical neurodevelopmental disorder","volume":"10","author":"Neul","year":"2004","journal-title":"Neuroscience"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: Revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1542\/peds.91.2.445","article-title":"Epidemiology of Rett syndrome: A population-based registry","volume":"91","author":"Kozinetz","year":"1993","journal-title":"Pediatrics"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13023-016-0499-7","article-title":"Rett syndrome: A wide clinical and autonomic picture","volume":"11","author":"Pini","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mrdd.10020","article-title":"Clinical manifestations and stages of Rett syndrome","volume":"8","author":"Hagberg","year":"2002","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/21678707.2016.1229181","article-title":"Neurobiologically-based treatments in Rett syndrome: Opportunities and challenges","volume":"4","author":"Kaufmann","year":"2016","journal-title":"Expert Opin. Orphan Drugs"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrneurol.2016.186","article-title":"Clinical and biological progress over 50 years in Rett syndrome","volume":"13","author":"Leonard","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.braindev.2004.10.008","article-title":"MeCP2 expression and function during brain development: Implications for Rett syndrome\u2019s pathogenesis and clinical evolution","volume":"27","author":"Kaufmann","year":"2005","journal-title":"Brain Dev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"12777","DOI":"10.1523\/JNEUROSCI.1102-10.2010","article-title":"CDKL5, a protein associated with Rett syndrome, regulates neuronal morphogenesis via rac1 signaling","volume":"30","author":"Chen","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0032-1308856","article-title":"Variant of Rett syndrome and CDKL5 gene: Clinical and autonomic description of 10 cases","volume":"43","author":"Pini","year":"2012","journal-title":"Neuropediatrics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s12264-014-1452-6","article-title":"MeCP2: Multifaceted roles in gene regulation and neural development","volume":"30","author":"Cheng","year":"2014","journal-title":"Neurosci. Bull."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/hmg\/ddy338","article-title":"Loss of MeCP2 in immature neurons leads to impaired network integration","volume":"28","author":"Sun","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41583-019-0177-6","article-title":"A cross-disorder connectome landscape of brain dysconnectivity","volume":"20","author":"Sporns","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMra1706158","article-title":"Mapping symptoms to brain Networks with the human connectome","volume":"379","author":"Fox","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/jnnp-2018-319581","article-title":"Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis","volume":"90","author":"McMackin","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1002\/hbm.24740","article-title":"Patterned functional network disruption in amyotrophic lateral sclerosis","volume":"40","author":"Dukic","year":"2019","journal-title":"Hum. Brain Mapp."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.25574","article-title":"Connectomic profiling Identifies responders to vagus nerve stimulation","volume":"86","author":"Mithani","year":"2019","journal-title":"Ann. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fnint.2020.00030","article-title":"Evoked potentials and EEG analysis in Rett syndrome and related developmental encephalopathies: Towards a biomarker for translational research","volume":"14","author":"Saby","year":"2020","journal-title":"Front. Integr. Neurosci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s11689-019-9275-z","article-title":"Electroencephalographic spectral power as a marker of cortical function and disease severity in girls with Rett syndrome","volume":"11","author":"Roche","year":"2019","journal-title":"J. Neurodev. Disord."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/acn3.533","article-title":"Placebo-controlled crossover assessment of mecasermin for the treatment of Rett syndrome","volume":"5","author":"Kaufmann","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Keogh, C., Pini, G., Dyer, A.H., Bigoni, S., Dimarco, P., Gemo, I., Reilly, R., and Tropea, D. (2018). Clinical and genetic Rett syndrome variants are defined by stable electrophysiological profiles. BMC Pediatr., 18.","DOI":"10.1186\/s12887-018-1304-7"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuron.2006.09.037","article-title":"Brain-specific phosphorylation of MeCP2 regulates activity-dependent bdnf transcription, dendritic growth, and spine maturation","volume":"52","author":"Zhou","year":"2006","journal-title":"Neuron"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1073\/pnas.96.1.254","article-title":"Neuroprotection with noninvasive neurotrophin delivery to the brain","volume":"96","author":"Wu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrn3209","article-title":"The many faces of insulin-like peptide signalling in the brain","volume":"13","author":"Fernandez","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/MOP.0b013e32834c9251","article-title":"Translational research","volume":"23","author":"Khwaja","year":"2011","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_29","first-page":"679801","article-title":"IGF1 as a potential treatment for Rett syndrome: Safety assessment in six Rett patients","volume":"2012","author":"Pini","year":"2012","journal-title":"Autism Res. Treat."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/brain\/aws096","article-title":"Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome","volume":"135","author":"Robinson","year":"2012","journal-title":"Brain"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1574889811308020004","article-title":"Insulin-like growth factor-1 and its derivatives: Potential pharmaceutical application for treating neurological conditions","volume":"8","author":"Guan","year":"2013","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9941","DOI":"10.1073\/pnas.1311685111","article-title":"Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett syndrome","volume":"111","author":"Castro","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep00045","article-title":"The short-time structural plasticity of dendritic spines is altered in a model of Rett syndrome","volume":"1","author":"Landi","year":"2011","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e1912","DOI":"10.1212\/WNL.0000000000007316","article-title":"Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome","volume":"92","author":"Glaze","year":"2019","journal-title":"Neurology"},{"key":"ref_37","first-page":"5073078","article-title":"Illness severity, social and cognitive ability, and EEG analysis of ten patients with Rett syndrome treated with mecasermin (recombinant human IGF1)","volume":"2016","author":"Pini","year":"2016","journal-title":"Autism Res. Treat."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1073\/pnas.1311141111","article-title":"Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF1) for the treatment of Rett syndrome","volume":"111","author":"Khwaja","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1523\/JNEUROSCI.5548-08.2009","article-title":"Massage accelerates brain development and the maturation of visual function","volume":"29","author":"Guzzetta","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0387-7604(01)00193-0","article-title":"Guidelines for reporting clinical features in cases with MECP2 mutations","volume":"23","author":"Kerr","year":"2001","journal-title":"Brain Dev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0006-3223(99)00137-7","article-title":"Early childhood predictors of adult anxiety disorders","volume":"46","author":"Kagan","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Nunez, P.L., and Srinivasan, R. (2006). Electric Fields of the Brain: The Neurophysics of EEG, Oxford University Press.","DOI":"10.1093\/acprof:oso\/9780195050387.001.0001"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nrn2575","article-title":"Complex brain networks: Graph theoretical analysis of structural and functional systems","volume":"10","author":"Bullmore","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Jolliffe, I. (2011). Principal component analysis. International Encyclopedia of Statistical Science, Springer.","DOI":"10.1007\/978-3-642-04898-2_455"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Keogh, C., Pini, G., Gemo, I., and Tropea, D. (2019). Statistical modelling of cortical Connectivity using non-Invasive electroencephalograms. J. Vis. Exp.","DOI":"10.3791\/60249"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Sch\u00f6lkopf, B., and Smola, A.J. (2002). Learning with Kernels: Support Vector Machines, Regularization, Optimization, and Beyond, MIT Press.","DOI":"10.7551\/mitpress\/4175.001.0001"},{"key":"ref_47","unstructured":"Ross, K.A., Jensen, C.S., Snodgrass, R., Dyreson, C.E., Jensen, C.S., Snodgrass, R., Skiadopoulos, S., Sirangelo, C., Larsgaard, M.L., and Grahne, G. (2009). Cross-validation. Encyclopedia of Database Systems, Springer."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13229-020-00359-w","article-title":"IGF1 treatment causes unique transcriptional response in neurons from individuals with idiopathic autism","volume":"11","author":"Linker","year":"2020","journal-title":"Mol. Autism"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fped.2014.00052","article-title":"Repeated insulin-like growth factor 1 treatment in a patient with Rett syndrome: A single case study","volume":"2","author":"Pini","year":"2014","journal-title":"Front. Pediatr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/brain\/awy323","article-title":"Towards a better diagnosis and treatment of Rett syndrome: A model synaptic disorder","volume":"142","author":"Banerjee","year":"2019","journal-title":"Brain"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"E4782","DOI":"10.1073\/pnas.1506499112","article-title":"MeCP2 regulates the timing of critical period plasticity that shapes functional connectivity in primary visual cortex","volume":"112","author":"Krishnan","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.neuroscience.2016.03.027","article-title":"Visual impairment in FOXG1-mutated individuals and mice","volume":"324","author":"Boggio","year":"2016","journal-title":"Neuroscience"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1093\/hmg\/ddx119","article-title":"Searching for biomarkers of CDKL5 disorder: Early-onset visual impairment in CDKL5 mutant mice","volume":"26","author":"Mazziotti","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24513","article-title":"Visual evoked potentials detect cortical processing deficits in Rett syndrome","volume":"78","author":"LeBlanc","year":"2015","journal-title":"Ann. Neurol."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/10\/8\/515\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:53:58Z","timestamp":1760176438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/10\/8\/515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":54,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]}},"alternative-id":["brainsci10080515"],"URL":"https:\/\/doi.org\/10.3390\/brainsci10080515","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]}}}